US Patents With Foreign Priority to Patent: 09167209
✉ Email this page to a colleague
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis | MAYZENT | siponimod | TABLET;ORAL | 209884-001 | Mar 26, 2019 | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | A METHOD OF TREATING MULTIPLE SCLEROSIS BY ADMINISTERING SIPONIMOD USING A TITRATION SCHEME TO REACH A MAINTENANCE DOSE | ||||
| Novartis | MAYZENT | siponimod | TABLET;ORAL | 209884-002 | Mar 26, 2019 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | A METHOD OF TREATING MULTIPLE SCLEROSIS BY ADMINISTERING SIPONIMOD USING A TITRATION SCHEME TO REACH A MAINTENANCE DOSE | ||||
| Novartis | MAYZENT | siponimod | TABLET;ORAL | 209884-003 | Aug 24, 2021 | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | A METHOD OF TREATING MULTIPLE SCLEROSIS BY ADMINISTERING SIPONIMOD USING A TITRATION SCHEME TO REACH A MAINTENANCE DOSE | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use |
